CAR-Immunotherapy TRIALS

CAR-Immunotherapy package has 22 parameters for all trials registered internationally from 2001 through 30 June 2020, including their current status. Cumulatively, 1036 CAR-Immunotherapy trials have been registered worldwide (see histogram below).

• Trial Data
  • Registration Year
  • Trial ID with link to trial on-line
  • Country
  • Phase
  • Status (updated as of 17 Sept. 2020)
• Patient Data
  • Indication
  • Patient Age Groups
  • Target Enrollment
• Cell Data
  • CAR Target
  • Cell Type
  • Cell Source
  • Donor Type
  • CAR Construct (costimulatory domain, vector, etc)
  • Cell Dose(s)
  • Mode of Administration (route and # doses)
  • Conditioning
  • Drug Support/Combos
• Sponsor Data
  • Academia or Industry Funding
  • Sponsor Name
  • Study Acronym
• Additional Information
  • Product Name
  • Notes - includes secondary trial IDs and reasons for termination

Below is a histogram of CAR-Immunotherapy trial numbers versus time, color-coded by trial phase. This illustrates the explosion of CAR-Immunotherapy trials since 2014 and the appearance of follow-up studies since 2015. During 2019, 33% of new CAR-Immunotherapy trials were not registered in ClinicalTrials.gov.

Attachment	Size
SAMPLE CAR-immunotherapy Trials	12.19 KB